Economic Cost of Adverse Events Per Course of Therapy with Commonly Used First-Line Regimens for the Treatment of Chronic Lymphocytic Leukemia
May 1, 2014, 00:00
10.1016/j.jval.2014.03.463
https://www.valueinhealthjournal.com/article/S1098-3015(14)00514-2/fulltext
Title :
Economic Cost of Adverse Events Per Course of Therapy with Commonly Used First-Line Regimens for the Treatment of Chronic Lymphocytic Leukemia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00514-2&doi=10.1016/j.jval.2014.03.463
First page :
A79
Section Title :
Cancer
Open access? :
No
Section Order :
1508